Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $2.5 million.

  • Jaguar Health's Other Operating Expenses fell 86.24% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 3167.11%. This contributed to the annual value of $9.6 million for FY2024, which is 878.44% up from last year.
  • Latest data reveals that Jaguar Health reported Other Operating Expenses of $2.5 million as of Q3 2025, which was down 86.24% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Other Operating Expenses ranged from a high of $4.2 million in Q1 2021 and a low of $1.9 million during Q1 2024
  • For the 5-year period, Jaguar Health's Other Operating Expenses averaged around $2.7 million, with its median value being $2.6 million (2022).
  • As far as peak fluctuations go, Jaguar Health's Other Operating Expenses plummeted by 5312.06% in 2021, and later skyrocketed by 6059.8% in 2025.
  • Quarter analysis of 5 years shows Jaguar Health's Other Operating Expenses stood at $2.8 million in 2021, then decreased by 18.94% to $2.2 million in 2022, then rose by 15.43% to $2.6 million in 2023, then rose by 26.38% to $3.3 million in 2024, then fell by 22.71% to $2.5 million in 2025.
  • Its Other Operating Expenses stands at $2.5 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.